APO RESEARCH · REPORT
Tuberculosis (TB) Diagnostics
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Product & engineering
Understand the product.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Selected research
Industry Growth & Trends
Global Tuberculosis (TB) Diagnostics Industry Growth and Trends Forecast to 2032
Market perspective
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
According to APO Research, the global Tuberculosis (TB) Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Tuberculosis (TB) Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tuberculosis (TB) Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tuberculosis (TB) Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tuberculosis (TB) Diagnostics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tuberculosis (TB) Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tuberculosis (TB) Diagnostics Market by Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Segment by Application
Diagnostic Laboratories
Hospitals
Tuberculosis (TB) Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tuberculosis (TB) Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
Applications
- Diagnostic Laboratories
- Hospitals
Companies covered
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tuberculosis (TB) Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tuberculosis (TB) Diagnostics Market Size by Region (2021-2032)
- 1.4.1 Global Tuberculosis (TB) Diagnostics Market Size by Region (2021-2026)
- 1.4.2 Global Tuberculosis (TB) Diagnostics Market Size by Region (2027-2032)
- 1.5 Key Regions Tuberculosis (TB) Diagnostics Market Size (2021-2032)
- 1.5.1 North America Tuberculosis (TB) Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tuberculosis (TB) Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate (2021-2032)
2 Tuberculosis (TB) Diagnostics Market by Type
- 2.1 Type Introduction
- 2.1.1 Culture-Based Diagnostics
- 2.1.2 Sputum Smear Microscopy
- 2.1.3 Rapid Molecular Diagnostics
- 2.1.4 Others
- 2.2 Global Tuberculosis (TB) Diagnostics Market Size by Type
- 2.2.1 Global Tuberculosis (TB) Diagnostics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tuberculosis (TB) Diagnostics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tuberculosis (TB) Diagnostics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tuberculosis (TB) Diagnostics Market Size by Regions
- 2.3.1 North America Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2021-2026)
3 Tuberculosis (TB) Diagnostics Market by Application
- 3.1 Type Introduction
- 3.1.1 Diagnostic Laboratories
- 3.1.2 Hospitals
- 3.2 Global Tuberculosis (TB) Diagnostics Market Size by Application
- 3.2.1 Global Tuberculosis (TB) Diagnostics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tuberculosis (TB) Diagnostics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tuberculosis (TB) Diagnostics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tuberculosis (TB) Diagnostics Market Size by Regions
- 3.3.1 North America Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tuberculosis (TB) Diagnostics Industry Trends
- 4.2 Tuberculosis (TB) Diagnostics Industry Drivers
- 4.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
- 4.4 Tuberculosis (TB) Diagnostics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tuberculosis (TB) Diagnostics Revenue (2021-2026)
- 5.2 Global Tuberculosis (TB) Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tuberculosis (TB) Diagnostics Key Company Headquarters & Area Served
- 5.4 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
- 5.5 Global Tuberculosis (TB) Diagnostics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tuberculosis (TB) Diagnostics Players Market Share by Revenue in 2025
- 5.6.3 2025 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Danaher
- 6.1.1 Danaher Company Information
- 6.1.2 Danaher Business Overview
- 6.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
- 6.1.5 Danaher Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Thermo Fisher Scientific
- 6.3.1 Thermo Fisher Scientific Company Information
- 6.3.2 Thermo Fisher Scientific Business Overview
- 6.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
- 6.3.5 Thermo Fisher Scientific Recent Developments
- 6.4 BD
- 6.4.1 BD Company Information
- 6.4.2 BD Business Overview
- 6.4.3 BD Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
- 6.4.5 BD Recent Developments
- 6.5 Abbott
- 6.5.1 Abbott Company Information
- 6.5.2 Abbott Business Overview
- 6.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
- 6.5.5 Abbott Recent Developments
- 6.6 Hologic
- 6.6.1 Hologic Company Information
- 6.6.2 Hologic Business Overview
- 6.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
- 6.6.5 Hologic Recent Developments
- 6.7 Qiagen
- 6.7.1 Qiagen Company Information
- 6.7.2 Qiagen Business Overview
- 6.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
- 6.7.5 Qiagen Recent Developments
- 6.8 BioMerieux
- 6.8.1 BioMerieux Company Information
- 6.8.2 BioMerieux Business Overview
- 6.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
- 6.8.5 BioMerieux Recent Developments
- 6.9 Hain Lifescience
- 6.9.1 Hain Lifescience Company Information
- 6.9.2 Hain Lifescience Business Overview
- 6.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
- 6.9.5 Hain Lifescience Recent Developments
- 6.10 Oxford Immunotec
- 6.10.1 Oxford Immunotec Company Information
- 6.10.2 Oxford Immunotec Business Overview
- 6.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
- 6.10.5 Oxford Immunotec Recent Developments
7 North America
- 7.1 North America Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 7.3 North America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 8.3 Europe Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 10.3 South America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst